Skip to main content

COVID-19 Topic Center

Expert Insights

Commentary
By Icario Team Health plans are making major blunders and erroneous assumptions when it comes to how they approach member HRAs; In this commentary, the Icario team explains how to solve these all-too-common missteps. Knowledge is power, right? It certainly can be, assuming you’re able to access…
Interview
By Julie Gould  According to recent study findings publishing online in Ageing Research Reviews, older adults with HIV infection are at increased risk of cognitive impairment. More specifically, this patient population is more at risk for cognitive impairment within the following domains:  …
Interview
By Edan Stanley Michael Drummond PhD, Professor of Health Economics, University of York, UK, and Allen Lising, Managing Director of FormularyDecisions, a part of AmerisourceBergen, offer insight from their recent study which assessed the current use of cost-effectiveness analyses in decision-making…
Commentary
By Jenn Dellwo, Icario  Feedback is a gift. We hear this phrase a lot and it’s particularly important for health plans assessing member satisfaction and how people feel about the care and customer service they receive. Properly analyzing satisfaction results is key, too—if plans are only hearing…
Interview
By Edan Stanley Diane Smith, PhD, associate director of reimbursement & policy Insights, Ana Stojanovska, vice president of commercial consulting, Matthew Sarnes, PharmD, senior vice president, business development & strategy, and Amanda O’Hora, senior director of reimbursement, policy and…
Interview
By Julie Gould Carmela Benson, director, real world value & evidence, Janssen Scientific Affairs, LLC, discusses recent research that examined Schizophrenia Population Health Management (SPHM) among adults in order to better understand how population health decision makers (PHDMs) prioritize…
Interview
By Edan Stanley Annie Yan, PharmD, manager of value & access strategy at Xcenda, a part of AmerisourceBergen, offers insight from study that evaluated payer-initiated oncology pathways (OCPs), in which trends in utilization, development, and barriers to implementation were measured. For this…
Interview
By Edan Stanley Tasmina Hydery, PharmD, MBA, BCGP, assistant director, integrated technology solutions, and Linnea Tennant, PharmD, MBA, MS, assistant director, value and access strategy, both from Xcenda, discuss their recent study which examined the Institute for Clinical and Economic Review (…
Commentary
By Icario Team To stay competitive, health plans must make member satisfaction and CAHPS a priority. Here are 5 ways to improve member interaction that can enhance retention and health along the way. Medicare Advantage (MA) members now have more choices than ever when it comes to the plans they…
Interview
By Julie Gould  Jenn Zerbato, PhD, post-doctoral research fellow, Peter Doherty Institute for Infection and Immunity, breaks down why HIV RNA could serve as a better measure of efficient latency reversal in both pre-clinical and clinical assessment of latency reversing agents (LRAs). What…
Back to Top